Senti Biosciences, Inc. (SNTI)
(Delayed Data from NSDQ)
$0.35 USD
-0.01 (-3.65%)
Updated May 23, 2024 04:00 PM ET
After-Market: $0.36 +0.01 (2.56%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth B Momentum F VGM
Cash flow Statements
Fiscal Year End for Senti Biosciences, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -71.06 | -58.21 | -3.86 | NA | NA |
Depreciation/Amortization & Depletion | 5.43 | 3.92 | 0.00 | NA | NA |
Net Change from Assets/Liabilities | 4.67 | 13.90 | 2.72 | NA | NA |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | NA | NA |
Other Operating Activities | 8.57 | 5.49 | -0.01 | NA | NA |
Net Cash From Operating Activities | -52.40 | -34.90 | -1.14 | NA | NA |
Property & Equipment | -11.93 | -41.37 | 0.00 | NA | NA |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | NA | NA |
Investments | 42.01 | -40.59 | 0.00 | NA | NA |
Other Investing Activities | 0.00 | 0.00 | -230.00 | NA | NA |
Net Cash from Investing Activities | 30.08 | -81.96 | -230.00 | NA | NA |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.89 | 1.40 | 232.56 | NA | NA |
Issuance (Repayment) of Debt | -0.11 | 5.18 | 0.00 | NA | NA |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | NA | NA |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | NA | NA |
Other Financing Activities | 0.00 | 111.98 | -0.52 | NA | NA |
Net Cash from Financing Activities | 0.78 | 118.55 | 232.03 | NA | NA |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | NA | NA |
Net Change In Cash & Equivalents | -21.54 | 1.70 | 0.89 | NA | NA |
Cash at Beginning of Period | 60.99 | 59.29 | 0.00 | NA | NA |
Cash at End of Period | 39.45 | 60.99 | 0.89 | NA | NA |
Diluted Net EPS | -1.60 | -2.23 | -0.17 | NA | NA |
Fiscal Year End for Senti Biosciences, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -12.11 | -71.06 | -52.34 | -37.42 | -18.72 |
Depreciation/Amortization & Depletion | 1.46 | 5.43 | 3.96 | 2.14 | 0.93 |
Net Change from Assets/Liabilities | 0.07 | 4.67 | -1.00 | -0.73 | -1.61 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | -1.10 | 8.57 | 4.35 | 6.03 | 3.10 |
Net Cash From Operating Activities | -11.68 | -52.40 | -45.36 | -29.98 | -16.30 |
Property & Equipment | -0.02 | -11.93 | -12.03 | -10.18 | -6.51 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 42.01 | 42.01 | 19.01 | -2.99 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -0.02 | 30.08 | 29.98 | 8.83 | -9.50 |
Uses of Funds
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.00 | 0.89 | 0.31 | 0.31 | 0.00 |
Issuance (Repayment) of Debt | 0.00 | -0.11 | -0.09 | -0.06 | -0.04 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | 0.00 | 0.78 | 0.22 | 0.25 | -0.04 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -11.70 | -21.54 | -15.16 | -20.90 | -25.84 |
Cash at Beginning of Period | 39.45 | 60.99 | 60.99 | 60.99 | 60.99 |
Cash at End of Period | 27.75 | 39.45 | 45.83 | 40.09 | 35.15 |
Diluted Net EPS | -0.26 | -0.42 | -0.34 | -0.42 | -0.42 |